In conclusion, although the choice of control material involves some particular challenges when studying ABO blood groups as a disease risk factor, our results confirm both a genetic and phenotypic association with pancreatic ductal adenocarcinoma. The gene discussed is ABO; the disease is pancreatic ductal adenocarcinoma.